These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 22356581)

  • 1. Association of IREB2 and CHRNA3 polymorphisms with airflow obstruction in severe alpha-1 antitrypsin deficiency.
    Kim WJ; Wood AM; Barker AF; Brantly ML; Campbell EJ; Eden E; McElvaney G; Rennard SI; Sandhaus RA; Stocks JM; Stoller JK; Strange C; Turino G; Silverman EK; Stockley RA; Demeo DL
    Respir Res; 2012 Feb; 13(1):16. PubMed ID: 22356581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of IREB2 and CHRNA3/5 polymorphisms with COPD and COPD-related phenotypes in a Chinese Han population.
    Zhou H; Yang J; Li D; Xiao J; Wang B; Wang L; Ma C; Xu S; Ou X; Feng Y
    J Hum Genet; 2012 Nov; 57(11):738-46. PubMed ID: 22914670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CHRNA3/5, IREB2, and ADCY2 are associated with severe chronic obstructive pulmonary disease in Poland.
    Hardin M; Zielinski J; Wan ES; Hersh CP; Castaldi PJ; Schwinder E; Hawrylkiewicz I; Sliwinski P; Cho MH; Silverman EK
    Am J Respir Cell Mol Biol; 2012 Aug; 47(2):203-8. PubMed ID: 22461431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL10 polymorphisms are associated with airflow obstruction in severe alpha1-antitrypsin deficiency.
    Demeo DL; Campbell EJ; Barker AF; Brantly ML; Eden E; McElvaney NG; Rennard SI; Sandhaus RA; Stocks JM; Stoller JK; Strange C; Turino G; Silverman EK
    Am J Respir Cell Mol Biol; 2008 Jan; 38(1):114-20. PubMed ID: 17690329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heritability of lung function in severe alpha-1 antitrypsin deficiency.
    DeMeo DL; Campbell EJ; Brantly ML; Barker AF; Eden E; McElvaney NG; Rennard SI; Stocks JM; Stoller JK; Strange C; Turino G; Sandhaus RA; Silverman EK
    Hum Hered; 2009; 67(1):38-45. PubMed ID: 18931508
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Korytina GF; Akhmadishina LZ; Viktorova EV; Kochetova OV; Viktorova TV
    Indian J Med Res; 2016 Dec; 144(6):865-876. PubMed ID: 28474623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding the role of the chromosome 15q25.1 in COPD through epigenetics and transcriptomics.
    Nedeljkovic I; Carnero-Montoro E; Lahousse L; van der Plaat DA; de Jong K; Vonk JM; van Diemen CC; Faiz A; van den Berge M; Obeidat M; Bossé Y; Nickle DC; Consortium B; Uitterlinden AG; van Meurs JJB; Stricker BCH; Brusselle GG; Postma DS; Boezen HM; van Duijn CM; Amin N
    Eur J Hum Genet; 2018 May; 26(5):709-722. PubMed ID: 29422661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exacerbations and duration of smoking abstinence are associated with the annual loss of FEV
    Fähndrich S; Bernhard N; Lepper PM; Vogelmeier C; Seibert M; Wagenpfeil S; Bals R
    Respir Med; 2017 Aug; 129():8-15. PubMed ID: 28732839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology, radiology, and genetics of nicotine dependence in COPD.
    Kim DK; Hersh CP; Washko GR; Hokanson JE; Lynch DA; Newell JD; Murphy JR; Crapo JD; Silverman EK;
    Respir Res; 2011 Jan; 12(1):9. PubMed ID: 21232152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissecting direct and indirect genetic effects on chronic obstructive pulmonary disease (COPD) susceptibility.
    Siedlinski M; Tingley D; Lipman PJ; Cho MH; Litonjua AA; Sparrow D; Bakke P; Gulsvik A; Lomas DA; Anderson W; Kong X; Rennard SI; Beaty TH; Hokanson JE; Crapo JD; Lange C; Silverman EK;
    Hum Genet; 2013 Apr; 132(4):431-41. PubMed ID: 23299987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loci identified by genome-wide association studies influence different disease-related phenotypes in chronic obstructive pulmonary disease.
    Pillai SG; Kong X; Edwards LD; Cho MH; Anderson WH; Coxson HO; Lomas DA; Silverman EK;
    Am J Respir Crit Care Med; 2010 Dec; 182(12):1498-505. PubMed ID: 20656943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health status and lung function in the Swedish alpha 1-antitrypsin deficient cohort, identified by neonatal screening, at the age of 37-40 years.
    Piitulainen E; Mostafavi B; Tanash HA
    Int J Chron Obstruct Pulmon Dis; 2017; 12():495-500. PubMed ID: 28203073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of airflow obstruction in severe alpha-1-antitrypsin deficiency.
    Demeo DL; Sandhaus RA; Barker AF; Brantly ML; Eden E; McElvaney NG; Rennard S; Burchard E; Stocks JM; Stoller JK; Strange C; Turino GM; Campbell EJ; Silverman EK
    Thorax; 2007 Sep; 62(9):806-13. PubMed ID: 17389752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clarification of the risk of chronic obstructive pulmonary disease in α1-antitrypsin deficiency PiMZ heterozygotes.
    Molloy K; Hersh CP; Morris VB; Carroll TP; O'Connor CA; Lasky-Su JA; Greene CM; O'Neill SJ; Silverman EK; McElvaney NG
    Am J Respir Crit Care Med; 2014 Feb; 189(4):419-27. PubMed ID: 24428606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Four SNPs in the CHRNA3/5 alpha-neuronal nicotinic acetylcholine receptor subunit locus are associated with COPD risk based on meta-analyses.
    Cui K; Ge X; Ma H
    PLoS One; 2014; 9(7):e102324. PubMed ID: 25051068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung function and CT lung densitometry in 37- to 39-year-old individuals with alpha-1-antitrypsin deficiency.
    Mostafavi B; Diaz S; Piitulainen E; Stoel BC; Wollmer P; Tanash HA
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3689-3698. PubMed ID: 30510411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individualized lung function trends in alpha-1-antitrypsin deficiency: a need for patience in order to provide patient centered management?
    Stockley RA; Edgar RG; Pillai A; Turner AM
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1745-56. PubMed ID: 27536086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of genomic and genetic approaches implicates IREB2 as a COPD susceptibility gene.
    DeMeo DL; Mariani T; Bhattacharya S; Srisuma S; Lange C; Litonjua A; Bueno R; Pillai SG; Lomas DA; Sparrow D; Shapiro SD; Criner GJ; Kim HP; Chen Z; Choi AM; Reilly J; Silverman EK
    Am J Hum Genet; 2009 Oct; 85(4):493-502. PubMed ID: 19800047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CHRNA3 variant for lung cancer is associated with chronic obstructive pulmonary disease in Korea.
    Kim WJ; Oh YM; Kim TH; Lee JH; Kim EK; Lee JH; Lee SM; Shin TR; Yoon HI; Lim SY; Lee SD
    Respiration; 2013; 86(2):117-22. PubMed ID: 23207642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variants in FAM13A and IREB2 are associated with the susceptibility to COPD in a Chinese rural population: a case-control study.
    Zhang Y; Qiu J; Zhang P; Zhang J; Jiang M; Ma Z
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1735-1745. PubMed ID: 29872291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.